CRISPR, Genome Editing, and Human Health

IGI researcher Matthew Kan joins JAMA Associate Editor W. Gregory Feero to discuss how CRISPR works and how CRISPR-based technologies are being used in ongoing trials to treat a wide variety of medical conditions.

CRISPR, Genome Editing, and Human Health
JAMA Author Interviews | JAMA | September 20, 2022